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Skin cancerThis study provides a ﬁrst characterisation of β-HPV life-cycle events in tumours abscised from EV patients
(the human model of β-HPV-induced skin cancer), and shows how changes in E4 expression patterns relate
to disease severity. β-HPV life-cycle has also been reconstructed in organotypic raft cultures created using
EV-derived keratinocytes. In EV lesions and raft cultures, abundant cytoplasmic E4 expression was detectable
in differentiating cells along with viral genome ampliﬁcation as reported for other HPV types. E4 expression
was also seen in PCNA-positive basal cells in some EV skin cancers as well as in tumours from HPV8CER
(Complete Early Region) transgenic mice. In these lesions, E4 staining extended throughout the full thickness
of the epithelium and was apparent in the markedly atypical cells. The loss of such staining at the tumour
border suggests a distinct type of E4 dysregulation that may be exploited as a marker of viral expression dur-
ing β-HPV-associated skin cancer progression.
© 2011 Elsevier Inc. All rights reserved.Introduction
Human Papillomaviruses (HPVs) are small DNA tumour viruses
that have a circular double-stranded DNA genome of ~8 kb in length,
which includes both non-structural early (E) and structural late (L)
genes. These viruses are strictly epitheliotropic, infecting keratino-
cytes at a wide range of body sites (zur Hausen, 2009). The virus life
cycle is tightly coupled to the differentiation process of the infected
squamous epithelium (Doorbar, 2005). Over 100 different types of
HPV have been identiﬁed to date and have been classiﬁed into several
phylogenetic groups (Bernard et al., 2010). Of these, the α-genus
HPVs associated with infections of mucosal epithelia, are the best
characterised.
Beta-HPVs are evolutionarily distinct from theα-genus, associated
with infections of mucosal epithelia (Bravo et al., 2010), and are asso-
ciatedwith widespread in-apparent or asymptomatic infections in the
general population (Antonsson et al., 2000; Feltkamp et al., 2008). In
immunosuppressed individuals however, and in individuals suffering
from the rare inherited disease Epidermodysplasia Verruciformis
(EV), these viruses can replicate unchecked, and have been implicatedand Experimental Medicine,
, Italy. Fax: +39 0321 620421.
).
rights reserved.in the development of non-melanoma skin cancer (NMSC) (Akgul
et al., 2006; Nindl et al., 2007; Pﬁster, 2003). EV is a rare, lifelong,
autosomal recessive skin disease associated with an unusual suscepti-
bility to infections with ubiquitous β-HPV, but not to infections with
other pathogens, including cutaneous and genital HPVs of the alpha,
gamma, mu, or nu genera. The disease appears early in childhood
and is characterised by disseminated polymorphic cutaneous lesions,
that undergo malignant transformation in more than 50% of patients
starting around the third decade of life (Jablonska and Majewski,
1994; Orth, 2006). Susceptibility to EV is inherited, and has been
linked to mutations in two EV sensitivity genes (EVER1 and EVER2)
(Lazarczyk et al., 2009; Ramoz et al., 2002). Immunosuppressed
patients such as organ transplant recipients (OTRs) somewhat resem-
ble EV patients. They have a signiﬁcantly increased risk of developing
β-HPV-associated NMSC (The SCOPE Collaborative Group, 2009). The
severity to which β-HPV infections can progress in OTR and EV pa-
tients indicates a pressing need for new antiviral strategies, which
may be developed once our basic understanding of this group of virus-
es has improved.
In this report, we have studied the β-HPV life cycle in a series of
tumours obtained from two EV patients carrying invalidating muta-
tions in the EVER2 gene. The sites of viral genome ampliﬁcation
and protein expression in their infected biopsy material were visua-
lised using ﬂuorescent in situ hybridisation (FISH) and indirect
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severity correlate with changes in β-HPV life-cycle events and E4
expression pattern. Interestingly, freshly isolated epidermal keratino-
cytes from EV patients could be successfully propagated in in vitro cell
culture, and could be used to establish organotypic raft cultures that
resemble the in vivo lesions with regard to E4 expression and sites of
genome ampliﬁcation. Use of the raft model alongside the HPV8 com-
plete early genome region (CER) transgenic mouse model, which was
also found to express E4 in tumours, is expected to advance our under-
standing of these viruses as our knowledge of events during natural
infection. Our ﬁndings also point to a role of E4 as a possible marker
of β-HPV infection and viral activity in skin cancers and their
precursors.
Results
Understanding the β-HPV life cycle in EV patients using DNA-FISH and
antibodies to E4 and PCNA
A series of skin tumours was obtained from two well-
characterised EV patients (named EVpt4 and EVpt5) (Dell'Oste
et al., 2009; Landini et al., 2011), who lacked the EVER2 protein as a
consequence of a germ line homozygous invalidating deletion in the
EVER2 gene. To characterise β-HPV life cycle events in these infected
biopsies, we used FISH to identify sites of viral genome ampliﬁcation,
along with the immunodetection of key viral and cellular proteins, in-
cluding E4 and PCNA. HPV DNA analysis was performed by PM-PCR in
EV lesions which revealed that in EVpt4, HPV5 was consistently found
in all lesions and in those reported here was the only genotype. In le-
sions from EVpt5, HPV14 was consistently found alone or in associa-
tion with other genotypes always from the β genus [SK, HPV14;
Bowenoid lesion (neck/2008), HPV14, 23, 24, 93; Bowenoid lesion
(ear/2005), HPV14, 23, 24, 92, 93; and SCC (ear/2008), HPV14].
To visualise E4, we used broadly cross-reactive polyclonal anti-
bodies raised against the E4 protein of two β-HPV types (HPV5 and
HPV8) after their expression as fusion proteins in bacteria and valida-
tion in ELISA and Western blotting against recombinant β-HPV E4
proteins (data not shown). Protein sequence alignment scores are
high between these HPV types and HPV14E4, as well as between
most of the genotypes belonging to the β1 species, which are pre-
dominant in both patients (see Supplementary data Table S1). Classi-
cal cytoplasmic E4 staining was apparent in lesions caused by
different members of the β1 group (see Figures hereinafter) in agree-
ment with conservation of epitopes amongst their E4 proteins.
For EVpt5, 13 biopsies were collected, including several squamous
cell carcinoma (SCC), Bowenoid lesions, and one wart-like lesion
which was histologically diagnosed as Seborrheic Keratosis (SK). Co-
immunostaining of HPV14-DNA by FISH and E4 by indirect immuno-
ﬂuorescence revealed, in the peripheral region of the SK (back/2007)
that showed moderate acanthosis and hyperpigmentation, the pres-
ence of many cells exhibiting intense HPV14 DNA-positive nuclei,
and cytoplasmic E4 staining in the more superﬁcial layers (Fig. 1A).
Viral genome ampliﬁcation coincided with the presence of detectable
levels of cytoplasmic E4, which is typical of what is seen with other
HPV types (Middleton et al., 2003; Peh et al., 2004). In contrast, with-
in the areas with pronounced acanthosis and numerous horn cysts,
viral genome ampliﬁcation was not readily detected. Abundant cyto-
plasmic E4 staining was detected in some differentiating cells in these
lesions (large arrow in Fig. 1A) but was also found elsewhere in the
lesion, including the basal layer with an apparently nuclear distribu-
tion (small arrows in Fig. 1B). PCNA expression overlapped with
this less-intense E4 staining in the hyperplastic thicker epithelium
where it extended throughout the full epithelial thickness. In con-
trast, in the areas showing HPV-DNA-positive nuclei, PCNA staining
decreased following the onset of E4 expression, although a region of
overlap was apparent where E4-PCNA double-positive cells could befound. An elevation of PCNA levels in the upper epithelial layers is
typically seen in low-grade HPV lesions in cells supporting genome
ampliﬁcation and this pattern appears to be preserved here. This
same staining pattern was obtained using the antibodies raised
against both E4 antisera (HPV5 and HPV8 E4) and no speciﬁc signal
was obtained with the pre-immune sera or following preabsorption
of the antibodies with an excess of speciﬁc antigen (data not shown).
The same staining was also performed on the twelve malignant
lesions available from the same patient. As shown in the representa-
tive picture in Fig. 2A, this co-immunostaining revealed in Bowenoid
lesions (neck/2008) the presence of many cells exhibiting intense
HPV14 DNA-positive nuclei and cytoplasmic E4 staining in the tu-
mour area displaying some residual morphological differentiation.
The expression pattern of PCNA overlapped that of E4 staining
where viral genome ampliﬁcation was occurring. In all cases, the
adjacent normal epithelium was negative for the viral markers
tested (E4 staining and FISH), and E4 expression perfectly overlapped
with the appearance of intraepithelial dysplasia (Figs. 2B and C) (ear/
2005).
Similar pictures were also observed in the SCC (ear/2008) with the
presence of HPV14-positive nuclei and cytoplasmic E4 in the area
were some morphological differentiation was still evident (Fig. 3A),
good overlap between E4 expression and PCNA (Fig. 3B) in the
more dysplastic area, and absence of any signal in the surrounding
normal epithelium.
Ten tumours were available for EVpt4, including 9 SCC and 1
Bowenoid lesion, but no wart-like lesion. In tumours from EVpt4, pos-
itive for the presence of HPV5, we found that cells expressing E4 were
widely distributed within the lesional tissue as shown in the SCC of
Fig. 4A (nose/2008a), although few of them were supporting β-HPV
genome ampliﬁcation. Where tissue orientation could be clearly
established (Fig. 4B, cheek bone/2007; basal layer shown by white
dotted line), low-level nuclear E4 was apparent prior to the onset of
cytoplasmic accumulation and genome ampliﬁcation. In this area,
that showed a low-grade region of intraepithelial dysplasia, many
HPV-DNA-positive cells were present in the superﬁcial layers, which
also showed cytoplasmic E4 immunoreactivity with the pattern large-
ly typical of low-grade disease. By contrast, in the areas of the SCC
(nose/2008b) that showed a loss of epithelial stratiﬁcation, markedly
atypical cells, and invasion into the underlying connective tissue
(Fig. 4C), most cells showed low-level E4 staining and PCNA-
positivity. Viral genome ampliﬁcation was not apparent in these
cells by FISH suggesting that viral genome ampliﬁcation was no lon-
ger occurring or that it was below the limits of detection using this
approach.
All in all, these results suggest that β-HPV infection and viral gene
expression are associated with the early events of skin cancer devel-
opment, but that life-cycle patterns can change signiﬁcantly as dis-
ease severity increases.
EVER2-null keratinocytes generate hyperplastic epithelium in raft
cultures that can support HPV replication
In parallel with the analysis of clinical material, we also wished to
evaluate the life-cycle of these viruses using in vitro systems, and in
particular, the organotypic raft model that has proved valuable for
the study of high-risk alpha papillomaviruses. To verify whether the
life cycle events observed in the EV skin lesions could be reproduced
in an in vitro model of β-HPV replication, epithelial organotypic raft
cultures were produced from freshly isolated keratinocytes obtained
either from non-lesional skin of EVpt4 or the perilesional skin of a
SCC of EVpt5, referred to as EV4- and EV5-rafts respectively. Both of
the EV-derived organotypic cultures appeared hyperproliferative
when compared with control raft cultures (Fig. 5A), and this was
also apparent from the pattern of PCNA expression in the suprabasal
strata. Viral DNA detection and type-speciﬁc Q-PCR demonstrated
Fig. 1. Distribution of ampliﬁed viral DNA, E4 and PCNA in a wart-like lesion (Seborrheic Keratosis) from EV patient 5. (A, B) H&E staining (top panels) of tissue sections from the
parafﬁn-embedded Seborrheic Keratosis. Serial sections were double stained (middle panels) for the presence of viral genome ampliﬁcation by DNA-FISH (HPV14 in red) and for E4
expression (green). In the lower panels, sections were double stained using antibodies to E4 (red) and PCNA (green). The region shown corresponds to the square highlighted in the
H&E images. All sections were counterstained with DAPI (blue) to visualise cell nuclei. The merged images are shown on the right. The broken lines indicate the position of the basal
layer. In A, the inset shows accumulation of dark granules in the superﬁcial layers and the large arrow indicates cytoplasmic E4 staining. In B, the small arrows indicate nuclear E4
staining. Scale bars=100 μm.
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viral load for HPV5 and HPV14 (≤1 copy/cell) and a slightly higher
viral load for HPV8 (30 copies/cell). In the EV5-raft, only HPV14
(209 copies/cell) was found. Consistent with this ﬁnding, HPV14DNA-positive nuclear signals of high intensity were detected in a
number of mid- to upper spinous cells in the area of the EV5-raft
where the epithelium was thicker and more hyperplastic (Fig. 5B).
Viral genome ampliﬁcation coincided with the presence of detectable
Fig. 2. Distribution of ampliﬁed viral DNA, E4, and PCNA in two Bowen's Disease (A, neck/2008; B and C, ear/2005) from EV patient 5. (A) H&E staining (top panels) of tissue sections
from the parafﬁn-embedded tumour. Serial sections were double stained (middle panels) for the presence of viral genome ampliﬁcation by DNA-FISH (HPV14 in red) and for E4
expression (green). The inset shows cells exhibiting intense HPV14 DNA-positive nuclei and cytoplasmic E4 staining. In the lower panels, sections were double stained using an-
tibodies to E4 (red) and PCNA (green). The region shown corresponds to the square highlighted in the H&E images. The merged images are shown on the right. (B, C) H&E staining
(left panels) of tissue sections from the parafﬁn-embedded tumour. Serial sections were double stained for the presence of viral genome ampliﬁcation by DNA-FISH (HPV14 in red)
and for E4 expression (green). All sections were counterstained with DAPI (blue) to visualise cell nuclei. The merged images are shown on the right. The broken lines indicate the
position of the basal layer. Scale bars=100 μm.
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sues with the HPV8 genome did not show any signal, very likely be-
cause the amount of viral DNA present in the cells was lower than
the detection limit of this technique. Accordingly, anti-E4 immunos-
taining was also negative (data not shown).
To verify whether the pattern of ampliﬁed viral DNA found in EV5-
raft reﬂected host DNA replication, we simultaneously visualised
BrdU incorporation by immunostaining and viral DNA by FISH.
BrdU-positive cells were distributed in the basal and suprabasal
layers in the EV5-raft as expected for a hyper-proliferating epithelium
(Fig. 5B, lower row), while they were restricted to just a few basal
cells in control raft cultures (data not shown). In addition, this co-
staining revealed that the majority of cells showing intense positive
staining for HPV14 DNA were negative for strong BrdU and vice
versa. These results are consistent with the observations obtained
with the α-Papillomaviruses (PVs), which showed that viral DNA am-
pliﬁcation did not occur concurrently with host DNA replication in Sphase, but rather that it follows host DNA replication (Wang et al.,
2009). As far as we know, this is the ﬁrst reconstruction of the β-
HPV life-cycle in vitro. Although propagation of β-HPV genomes in
primary keratinocytes is (in our experience) not as straightforward
as the propagation of high-risk α-types, the similarity between β-
HPV life-cycle events in the raft model and in naturally occurring dis-
ease encourages further development of this approach.
Identiﬁcation of the E4 protein in the HPV8 transgenic mouse model of
high-grade β-HPV disease
The antibodies were also validated in the HPV8 complete early
genome region (CER) transgenic mouse model; an established exper-
imental model of β-HPV-induced skin carcinogenesis (De Andrea et al.,
2010; Schaper et al., 2005). Following SDS-gel electrophoresis and
Western blotting of protein extracts from papillomas spontaneously
arising in these mice, the E4 antibodies detected a major band of
Fig. 3. Distribution of ampliﬁed viral DNA, E4, and PCNA in a SCC (ear/2008) from EV patient 5. (A and B, top panels) H&E staining of tissue sections from the parafﬁn-embedded
SCC. In the lower panels of A, serial sections were double stained for the presence of viral genome ampliﬁcation by DNA-FISH (HPV14 in red) and for E4 expression (green). In the
lower panels of B, serial sections were double stained for the presence of E4 expression (red) and PCNA (green). The region shown corresponds to the square highlighted in the
corresponding H&E images. All sections were counterstained with DAPI (blue) to visualise cell nuclei. The merged images are shown on the right. The broken lines indicate the
position of the basal layer. Scale bars=100 μm.
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mice (Fig. 6A, lanes 1 and 2). An anti-E4-reactive band with the same
molecularweightwas also found in extracts from 293 T cells transiently
overexpressing the E4 protein from a pCI-neo expression vector, but not
in cells transfected with the empty vector (Fig. 6A, lanes 3 and 4). The
antibodies raised against HPV5 E4 recognised the same protein species
when blotted against the same extracts (data not shown). The size
of the band was larger than that expected from the predicted E4
open reading frame (229 amino acids), and may reﬂect anomalous
migration which might be expected given the high proline content of
the protein.
Immunoﬂuorescence analysis of papillomas from HPV8CER mice,
showed that E4 expression was present throughout the epidermis
and had a cytoplasmic distribution in the upper epithelial layers
(Fig. 6B). In the non-lesional skin, staining was restricted to the
basal and suprabasal layers (Supplementary Fig. S1). In the basal
cells, the staining was predominantly nuclear, and was maintained
in regions of high grade intraepithelial dysplasia (SCC), as seen in
some of the naturally-occurring patient material. No E4 staining was
detected in skin sections from wild type control mice.
Since expression of the HPV8 early region is controlled by the ker-
atin 14 (K14) promoter in these transgenic mice, the expression in the
upper epithelial layers could simply reﬂect increased K14 promoter
activity in response to dysplasia, or be driven by an endogenouspromoter (in addition to K14), analogous to the differentiation-
dependent promoter reported for E4 in other genotypes (Karlen and
Beard, 1993; Karlen et al., 1996; Zhao et al., 1997). However, although
this model cannot be fully representative of the beta life cycle, some
molecular aspects of their biology may be investigated using this sys-
tem. The ﬁnding of abundant E4 expression in tumour cells from these
mice conﬁrms that this protein can be maintained in the more dys-
plastic areas of β-HPV-induced skin cancer, and suggests an intriguing
difference from the pattern observed in β-HPV induced lesions, where
E4 expression is progressively lost during cancer progression.
Discussion
This study provides a ﬁrst characterisation of β-HPV life-cycle
events in tumours abscised from EV patients, and provides an under-
standing of how changes in E4 expression patterns relate to disease
severity. In addition, we show that the β-HPV life-cycle can be recon-
structed in organotypic raft cultures created using EV-derived kerati-
nocytes. Although the rarity of EV disease limits the availability of
patient material, our data suggests that the analysis of naturally-
occurring disease coupled with the use of raft culture and transgenic
models, may together allow a clearer understanding of the events
that lead to β-HPV-associated cancers in EV patients. The insight
gained into the carcinogenetic role of β-HPV in these patients will
Fig. 4. Distribution of ampliﬁed viral DNA, E4, and PCNA in three SCC (A nose/2008a; B nose/2008b; and C right cheek/2007) from EV patient 4. (A) H&E staining (left panel) of
tissue sections from the parafﬁn-embedded SCC (nose/2008a). Serial sections were double stained for the presence of viral genome ampliﬁcation by DNA-FISH (HPV5 in red)
and for E4 expression (green). The arrow indicates HPV5-positive nuclei. All sections were counterstained with DAPI (blue) to visualise cell nuclei. The merged images are
shown on the right. (B) H&E staining (left panel) of tissue sections from the parafﬁn-embedded SCC (right cheek/2007). Serial sections were double stained for the presence of
viral genome ampliﬁcation by DNA-FISH (HPV5 in red) and for E4 expression (green). All sections were counterstained with DAPI (blue) to visualise cell nuclei. The merged images
are shown on the right. (C) H&E staining (top panels) of tissue sections from the parafﬁn-embedded SCC (nose/2008b). Serial sections were double stained for the presence of viral
genome ampliﬁcation by DNA-FISH (HPV5 in red) and for E4 expression (green) (middle panels) and E4 expression (red) and PCNA (green) (lower panels). The region shown cor-
responds to the red square highlighted in the H&E images. All sections were counterstained with DAPI (blue) to visualise cell nuclei. The merged images are shown on the right. The
broken lines indicate the position of the basal layer. Scale bars=100 μm.
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also in non-EV patients.
In the wart-like lesion from EVpt5 (deﬁned as SK), as well as in all
areas of the tumours obtained from both patients 4 and 5 where there
was still some morphological differentiation of the epithelium, the
ﬁrst appearance of the intense cytoplasmic E4 staining corresponded
closely with a positive FISH signal for viral DNA in the nuclei. This is
similar to what has been seen with other PV types, where the onset
of vegetative viral genome ampliﬁcation coincides closely with the
expression of cytoplasmic E4 during productive infection (Doorbar
et al., 1997; Nakahara et al., 2005; Peh et al., 2002). This was also
apparent in the more differentiated and productive areas of the ma-
lignant β-HPV-associated EV tumours. An intriguing ﬁnding however,
was the observation that a lower level of E4 expression was also de-
tectable in the PCNA-positive basal cells of some of the EV skincancers. In these lesions, E4 staining extended throughout the full
thickness of the epithelium and was apparent in the markedly atypi-
cal cells that were inﬁltrating into the underlying connective tissues.
This staining pattern suggests a potentially important difference be-
tween β-HPV-induced skin cancers and cancers caused by the high-
risk α-genotypes. Indeed, during abortive infection, as exhibited by
HPV16 during cancer progression in high-grade squamous intrae-
pithelial lesions (HSIL) of the cervix, the extent of E4 expression is
progressively reduced and correlates inversely with disease severity
(Doorbar, 2007; Middleton et al., 2003). In both the β and α-
genotypes however, it appears that changes in gene expression may
be exploited in assessing the disease severity (Doorbar, 2007; Peh
and Doorbar, 2005). The loss of such staining at the tumour border
suggests a distinct type of E4 dysregulation that may be exploited as
a marker of viral expression during β-HPV-associated skin cancer
Fig. 5. Histological appearance of organotypic raft cultures generated with EVER2 null keratinocytes, PCNA staining, and visualization of β-HPV replication. (A) Tissue sections from
parafﬁn-embedded raft cultures of normal keratinocytes (Ctrl-raft) or EV-derived keratinocytes isolated from non-lesional skin of EVpt4 and the perilesional skin of the SCC (scalp/
2008) of EVpt5, referred to as EV4- and EV5-rafts respectively, were stained with H&E (upper row). In the lower row, immunohistochemistry of serial sections of the raft specimens
shown in the upper row stained for PCNA. Dark brown, positive cells; blue, nuclear counterstaining. Scale bars=100 μm. (B) H&E staining (top panels) of tissue sections from the
parafﬁn-embedded EV5-raft. In the middle panels, serial sections from EV5-rafts were double stained for the presence of viral genome ampliﬁcation by DNA-FISH (HPV14 in red)
and for E4 expression (green). In the lower panels, sections were probed for HPV14 DNA (red) and incorporated BrdU (green) after an 18 hours exposure immediately prior to
harvesting. All sections were counterstained with DAPI (blue) to visualise cell nuclei. The region shown corresponds to the square highlighted in the H&E images. The merged im-
ages are shown on the right. The broken lines indicate the position of the basal layer.
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ing patterns in β-HPV-positive skin cancers from immunosuppressed
patients indicate that a pattern of expression similar to those seen
here in EV patients can be found, especially in low-grade lesions (CB,
MG and JD, unpublished results).
In this study,we also show that EVER2 null keratinocytes can give rise
to a hyperplastic and hyperkeratotic epithelium, even in the EV4-rafts
where HPV viral loads were quite low. This suggests that lack of the
EVER2 protein per semay be sufﬁcient to stimulate keratinocyte prolifer-
ation and differentiation. This ﬁnding is consistent with a previous study
showing higher growth rate of HPV-uninfected EVER2−/− keratinocytes
derived from EV patients when compared to that of cells with a wild-type EVER2 gene (Lazarczyk et al., 2008). It is possible that such
hyperproliferation might provide a favourable environment for β-
HPV virus replication. Indeed, these cultures were able to support
endogenous HPV replication and genome ampliﬁcation, as visualised
by the presence of many suprabasal HPV DNA-positive nuclei by
FISH, and abundant cytoplasmic E4. The detection of viral genome
ampliﬁcation in cells that were no longer able to incorporate BrdU,
suggests that as for the α-genotypes, viral genome ampliﬁcation oc-
curs after host DNA replication in cells that are progressing from S-
phase into G2 (Galloway, 2009; Wang et al., 2009). Of the various
PV proteins, E4 is amongst the most divergent both at the level of se-
quence homology and length, and is also (where examined) themost
Fig. 6. Identiﬁcation of the E4 protein in HPV8CER transgenic mice and transfected 293 T cells. (A) Western Blot analysis of E4 expression in equivalent amounts (30 μg) of cell
extracts from epidermal lysates from nontransgenic wild type (WT) mice (lane 1), papilloma obtained from HPV8CER transgenic mice (pooled from three animals) (lane 2),
293 T cell transfected with empty pCI-neo (lane 3), and 293 T expressing the E4 protein from a pCI-neo expression vector (lane 4). The proteins were blotted onto nitrocellulose
membranes, incubated with anti-HPV8E4 antibodies and visualised by chemiluminescence. β-actin served as a loading control. (B) Tissue sections of parafﬁn-embedded papilloma
from HPV8CER transgenic mice were double stained using antibodies to E4 (red) and PCNA (green). The merged image is shown in the lower panel. Scale bars=25 μm.
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expressed at levels higher than the L1 capsid protein. As discussed
previously, its high-level expression makes it a good marker of
gene-expression deregulation in naturally-occurring lesions, includ-
ing β-HPV induced skin cancers in EV patient as demonstrated in this
report (Doorbar et al., 1997; Peh and Doorbar, 2005). Its localisation
to the upper strata of benign lesions in cells containing high copy
numbers of viral DNA, coupled with the results from mutational an-
alyses in rabbit skin and in organotypic raft cultures, has pointed to a
principal role of the E4 protein as a late protein involved in viral rep-
lication and virion maturation (Doorbar et al., 1997; Middleton et al.,
2003; Nakahara et al., 2005; Roberts, 2006). However, the appear-
ance of the transcripts spanning the E4 region in the basal/parabasal
layer of a HPV6/11 lesions, and the ﬁnding that E4 is expressed in
these layers in lesions caused by COPV, HPV1, 4 and 65, suggest
that it may have other functions in some papillomavirus types
(Nakahara et al., 2005; Nicholls et al., 1999, 2001; Peh and Doorbar,
2005; Purdie et al., 2005). The overall identity between the HPV8
and HPV5 genome is 77%, and for the E1^E4 protein this is 65%. A
much lower identity is apparent when comparisons are made with
HPV1 E1^E4 (21%) and HPV16 E1^E4 (13%). Consistent with this
low homology, the consensus sequences found in HPV1 and HPV16
that have been associated with biological activities, such as keratin
binding and phosphorylation by Cdk2/cyclinA (Davy et al., 2006;
Doorbar et al., 1988, 1991; Roberts et al., 1993, 1994), are not pre-
cisely conserved in the E4 protein of the β-genotypes.
The HPV8 transgenic mouse model of high-grade β-HPV disease
model showed that E4 expression may sometimes be maintained in
β-HPV induced skin cancer, as demonstrated by indirect immunoﬂu-
orescence. The abundant E4 expression observed in tumours sponta-
neously arising in these mice resembles the pattern seen in some of
the naturally-occurring tumours from EV patients, as E4 staining ex-
tended throughout the full thickness of the tumour area.When taken together, our ﬁndings suggest that β-HPV E4 dysre-
gulation in tumour cells is associated with changes in disease sever-
ity, and also that E4 staining may be a useful biomarker of viral
activity in some skin cancers. The study also highlights the value of
examining β-HPV activity in EV patients, which represent an oppor-
tune humanmodel of β-HPV infection fromwhich we can obtain key
insight into the carcinogenetic role of β-HPV.
Materials and methods
Patients and cell cultures
Two unrelated Caucasian patients affected by EV were included in
this study. Human epidermal keratinocytes (HEK) were isolated from
skin biopsies as previously described (Akgul et al., 2005). Pooled pri-
mary human epidermal keratinocytes (HEK) and ﬁbroblasts (HFF)
from healthy donors were obtained from Clonetics and ATCC respec-
tively. HEK were maintained in EpiLife® Medium (Invitrogen, Milan,
Italy). HFF were cultivated in DMEM supplemented with 10% heat-
inactivated foetal bovine serum (FBS).
Epithelial raft cultures were prepared as previously described
(Azzimonti et al., 2009; Ojeh et al., 2001). To mark cells in S phase,
BrdU (5′-bromo-2′-deoxyuridine, 50 μg/ml) was added to the medi-
um 18 h before harvesting the raft cultures.
HPV-DNA detection and Quantitative real-time PCR (Q-PCR)
DNA extraction from formalin-ﬁxed parafﬁn-embedded skin biop-
sies and organotypic raft cultures was performed using the QIAamp
Tissue Kit (Qiagen) according to the manufacturer's instruction. β-
HPV-DNA analysis was performed as previously described using
broad spectrum PCR (PM-PCR) in combination with a reverse
203C. Borgogna et al. / Virology 423 (2012) 195–204hybridisation system (RHA) [Skin (beta) HPV assay; Diassay BV, Rijs-
wijk, The Netherlands] (de Koning et al., 2006; Dell'Oste et al., 2009).
Type-speciﬁc Q-PCR protocols for HPV5, 8 and 14 were performed
on a GeneAmp 7000 Sequence Detection System (Applied Biosys-
tems, Milan, Italy), using previously described primers (Dell'Oste
et al., 2009; Schaper et al., 2005).
Generation of antibodies
HPV5 and HPV8 sequences were obtained from GenBank. DNA
comprising the full-length spliced E1^E4 gene was cloned into the
EcoRI–SalI sites of pGEX-4T-1 (GE Healthcare) using standard
methods. The primers used to prepare the E1^E4 genes of each
virus type are listed below. For HPV5, the forward primer was
E4HPV5f (5′-GGA ATT CAG AAT GAC GGA TCC TAA TTC TAA AGC
TCC ACG CCT CCA GGG TCG CCA GGA G-3′) and the reverse primer
was E4HPV5r (5′-GCT CTA GAG TCG ACC TAT TAC TGG GGG GTC
GCG AGC TTC TTC CA-3′). For HPV8, the forward primer was
E4HPV8f (5′-GGA ATT CAG AAT GGC GGA TCA TAA AGC TCC ACC
CCC CCC GGA TCA CCA CCA G-3′) and the reverse primer was
E4HPV8r (5′-GCT CTA GAG TCG ACC TAT TAC TGG GGG GTC GAT
AGC TTC GTC CA-3′). The integrity of the clones was established by
automatic DNA sequencing, using an ABI machine. Glutathione
S-transferase (GST)-E1^E4 fusion protein was used as antigen to gen-
erate speciﬁc E1^E4 antibodies in rabbits. Rabbits were immunised at
multiple subcutaneous sites with 250 μg of protein in Freund's com-
plete adjuvant, followed by booster immunizations at 14-day inter-
vals with the 250-μg antigen in Freund's incomplete adjuvant.
Antibody titres were evaluated by ELISA 14 days after the third injec-
tion. Preimmune serum was collected before the immunization pro-
tocol was started and was used as a control in the immunostaining
experiments.
Plasmids and transfections
The E4 cDNA of HPV5 genomic clone was generated by PCR using
the following primers: fE4HPV5Eco, 5′-CGG GAA TTC ACC ATG AAG
TTA ATA AGG AAA CTG TGT TTG-3′ and rE4HPV5Xho, 5′-AGC TCG
AGT TAC TGG GGG GTC GCG AGC T-3′ (coding sequences are under-
lined; a Kozak sequence was added to forward primer and an ATG
codon was added for E4 amplicon). Plasmid pSC-B-HPV5 containing
a HPV5 genomic clone was used as template. The resulting cDNA
was digested with EcoRI and XhoI and ligated in the EcoRI/SalI sites
of the restricted pCI-neo plasmid (Promega). The correct DNA se-
quence of the insert was conﬁrmed by DNA sequencing.
293 T cells were purchased from the American Type Culture
Collection (Manassas, VA) and were cultured in minimal essential
medium containing 10% foetal calf serum. Before transfection, 293 T
cells were seeded onto dishes and grown to 70% conﬂuence. The
expression plasmid vectors pCI-neo and pCI-neo containing E4HPV5
cDNA were transfected into 293 T cells using CellPhect Tranfection
kit (GE Healthcare Life Sciences). Cells were harvested 48 h after
transfection.
Western blotting
Epidermal lysates were prepared as previously described, but
with some modiﬁcations (De Andrea et al., 2010; Doorbar et al.,
1986). Peeled epidermis and cell lysates were lysed in 5 M urea,
10% SDS and DTT as previously described (Doorbar et al., 1986).
Equal amounts of cell extracts (30 μg protein) were fractionated by
electrophoresis on SDS-polyacrylamide gels (12.5%) and transferred
to a nitrocellulose membrane (GE Healthcare). Membranes were
probed using the following antibodies: rabbit anti-HPV8/5E4
(1:600), mouse anti-beta-actin (clone AC-15 Sigma, 1:2000), and
peroxidase-coupled goat anti-rabbit or anti-mouse antibody (GEHealthcare), followed by antibody detection using an enhanced chemi-
luminescence kit (GE Healthcare).
DNA–protein (FISH) or protein–protein (IF) double detection
Immunoﬂuorescent detection of antigens coupled to DNA-FISH
was performed on formalin-ﬁxed parafﬁn-embedded skin biopsies
and organotypic raft cultures as previously described (Peh and
Doorbar, 2005).
The immunoﬂuorescent protein–protein double detection was
carried out after dewaxing, rehydration, antigen retrieval and block-
ing non-speciﬁc binding as described above. Slides were incubated
with a mixture containing two different primary antibodies diluted
in 5% NGS-PBS as follows: rabbit anti-HPV5 E4 or anti-HPV8 E4
(1:250) with mouse anti-PCNA (clone PC10, Santa Cruz Biotechnolo-
gy, 1:4000). Images were acquired using a DM6000B inverted ﬂuo-
rescence microscope equipped with a DFC350FX digital camera
(Leica Microsystems, Wetzlar, Germany). For assessment of histo-
logical features, the slides analysed by FISH-IF were disassembled
and stained with hematoxylin and eosin. For PCNA immunohisto-
chemistry, the slides were incubated with the biotinylated universal
anti-rabbit/mouse secondary antibody followed by incubation with
the streptavidin-horseradish peroxidase complex (Vector Laborato-
ries, Burlingame, CA). Bound antibodies were visualised by 3,3′dia-
minobenzidine, counterstained with Mayer's Haematoxylin, and
mounted with VectaMount permanent mounting medium (Vector
Laboratories).
Antibody absorption by antigen peptide was also performed as
control. The anti-HPV5/8E4 polyclonal antibodies were incubated at
their working dilution (1:250) in 5% normal goat serum (NGS)-PBS
with the speciﬁc antigen in a ratio of 1 mol:20 mol respectively.
These mixtures were incubated with rotating overnight at 4 °C. The
antigen/antibody complexes were spun down with a full speed cen-
trifugation and the resulting supernatants were used in place of the
primary antibody with the procedure described above.
Computational analysis
Alignments were performed using free ALIGN Query software
(Genestream Search network server IGH Montpellier, France; http://
xylian.igh.cnrs.fr/bin/align-guess.cgi) by using full-length sequences
reported in the Papilloma Virus Episteme (PaVE; http://pave.niaid.
nih.gov/#home).
Supplementary materials related to this article can be found online
at doi:10.1016/j.virol.2011.11.029.
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